The Series B funding was extended by 25 million euros to reach a total of 42 million euros The new funding enables a further expansion of the Temedica.
15.03.2022 Temedica announces cooperation with Bristol Myers Squibb for the development of a digital companion for psoriasis patients | app | digital | digital health